{"sourcedb":"DevicePMAs@therightstef","sourceid":"P980012_S005","text":"Approval for several specific engineering enhancements to the implanted (pump/drive unit, blood conduits, and percutaneous lead) components of the novacor n100pc lvas system as well as modifications to the software to upgrade to the n100pcq lvas system.  The device, as modified, will be marketed under the trade name novacor n100pcq lvas system and is indicated for use as a bridge to transplantation in cardiac transplant candidates at risk of imminent death from nonreversible left ventricular function for use both inside and outside the hospital.","project":"consensus_PMA_Age_Indications"}